CenterPoint Energy, Inc. · CNP · FY2026 Q2 · Calendar Q3 2026

CenterPoint reaffirms 2026 outlook as large-load investment expands

The quarter supports a constructive growth case built on large-load demand, transmission investment, and rate recovery, but it is not yet a low-execution-risk story. Reaffirmed guidance and identified cash-flow tailwinds are supportive; ERCOT approvals, capex delivery, regulatory outcomes, and financing conditions are the key tests.

Reported Before market openNYSEUtilities $24.93B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.40 Consensus $0.37
EPS surprise +7.2% Reported versus consensus
Reported revenue $2.15B Consensus $2.12B
Revenue surprise +1.3% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +0.2% Event window
SPY move +0.2% Same window
Abnormal move -0.0% Stock minus SPY
Volume 1.2× Versus trailing sessions
Subsequent drift -11.7% Up to 20 sessions
CNPSPY benchmark

Ask FN2 about CNP FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted 14 GW of batch-zero-eligible projects, added $1.2 billion to the 10-year capital plan without a new equity raise, and emphasized demand-charge and temporary-generation-unit cash-flow opportunities. The full-year EPS outlook remained unchanged.

Guidance delta

Full-year 2026 non-GAAP EPS guidance was reaffirmed at $1.89-$1.91.

Key takeaways

  • Q2 non-GAAP EPS was $0.40, and full-year 2026 guidance was maintained.
  • Management highlighted 14 GW of batch-zero-eligible projects and a potential system peak increase of more than 65%.
  • CenterPoint announced $1.2 billion of incremental capital for system upgrades and downtown Houston revitalization without a new equity raise.
  • Demand charges, temporary-generation-unit marketing, and Indiana projects are identified as cash-flow and growth opportunities.
  • Execution, regulatory approvals, transmission timing, financing costs, and potential equity needs remain the principal constraints.

Management priorities

  • Advance ERCOT batch-zero projects and related transmission upgrades.
  • Deploy the incremental capital plan, including downtown Houston revitalization.
  • Progress Indiana large-load opportunities and associated generation and transmission work.
  • Advance rate-case, regulatory, financing, and Ohio Gas LDC-sale initiatives.

Follow CNP with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CNP EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $0.53 Q1 '24 actual $0.55, beat Q2 '24 estimate $0.32 Q2 '24 actual $0.36, beat Q3 '24 estimate $0.32 Q3 '24 actual $0.31, match Q2 '25 estimate $0.38 Q2 '25 actual $0.29, miss Q3 '25 estimate $0.45 Q3 '25 actual $0.50, beat Q4 '25 estimate $0.45 Q4 '25 actual $0.45, match Q1 '26 estimate $0.55 Q1 '26 actual $0.56, beat Q2 '26 estimate $0.37 Q2 '26 actual $0.40, beat Q3 '26 estimate $0.49 Q4 '26 estimate $0.47 Q1 '27 estimate $0.61
Show 1 more >

Analyst Consensus ?

ConsensusHold30 ratings
Bullish1343.3%
Neutral1756.7%
Bearish00.0%

Analyst 52W Price Targets

$37.16Current
$29Low
$40.48Average
$50High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Morgan Stanley Equal Weight Equal WeightMaintainSep 18, 2026
Evercore ISI Group In Line In LineMaintainAug 17, 2026
Truist Securities Buy BuyMaintainAug 4, 2026
Keybanc Overweight OverweightMaintainJul 23, 2026
BMO Capital Outperform OutperformMaintainJul 22, 2026
JP Morgan Neutral NeutralMaintainJul 16, 2026
Jefferies Buy BuyMaintainApr 16, 2026
Barclays Equal Weight Equal WeightMaintainApr 15, 2026
B of A Securities Neutral NeutralMaintainApr 15, 2026
Wells Fargo Overweight OverweightMaintainJan 20, 2026
UBS Buy BuyMaintainDec 17, 2025
Scotiabank Sector Outperform Sector OutperformMaintainOct 24, 2025
Mizuho Neutral NeutralMaintainSep 30, 2025
Guggenheim Buy BuyMaintainFeb 21, 2024
RBC Capital Outperform OutperformMaintainSep 6, 2023
Credit Suisse Outperform OutperformMaintainApr 26, 2022
Citigroup Neutral NeutralMaintainFeb 23, 2022
Goldman Sachs Neutral BuyDowngradeJan 13, 2022
CFRA Hold HoldMaintainMay 7, 2020
SunTrust Robinson Humphrey Hold BuyDowngradeNov 15, 2019
Guggenheim Securities Neutral BuyDowngradeNov 15, 2019
Bank of America Neutral BuyDowngradeNov 15, 2019
Argus Buy BuyMaintainMay 5, 2018
Deutsche Bank Hold HoldMaintainAug 8, 2016
Tudor Pickering Hold BuyDowngradeJul 5, 2016
Argus Research Buy BuyMaintainMar 24, 2016
Macquarie Neutral NeutralMaintainJan 28, 2016
Ladenburg Thalmann Neutral NeutralMaintainJul 7, 2015
Wolfe Research Peer Perform OutperformDowngradeNov 26, 2013
Bank oferica Buy BuyMaintainMay 4, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $37.16. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
RBC CapitalStephen D\'Ambrisi$40$38.65 +7.6%Sep 15, 2026
Evercore ISIAnalyst unavailable$43$40.83 +15.7%Aug 17, 2026
Truist FinancialAnalyst unavailable$46$41.92 +23.8%Aug 4, 2026
Wolfe ResearchSteve Fleishman$49$44.2 +31.9%Jul 29, 2026
KeyBancSophie Karp$46$43.68 +23.8%Jul 23, 2026
Morgan StanleyDavid Arcaro$40$43.43 +7.6%Jul 22, 2026
BMO CapitalAnalyst unavailable$48$43.12 +29.2%Jul 15, 2026
JefferiesAnalyst unavailable$50$42.82 +34.6%Jun 18, 2026
Truist FinancialRichard Sunderland$47$41.53 +26.5%May 18, 2026
Evercore ISIAnalyst unavailable$45$43.52 +21.1%May 4, 2026
Wells FargoAnalyst unavailable$48$42.7 +29.2%Apr 21, 2026
JefferiesJulien Dumoulin-Smith$49$42.82 +31.9%Apr 16, 2026
BarclaysAnalyst unavailable$44$42.9 +18.4%Apr 15, 2026
Mizuho SecuritiesAnalyst unavailable$44$43 +18.4%Feb 23, 2026
Morgan StanleyAnalyst unavailable$37$39.59 -0.4%Jan 21, 2026
Wells FargoShahriar Pourreza$47$39.71 +26.5%Jan 20, 2026
BarclaysAnalyst unavailable$38$39.06 +2.3%Jan 15, 2026
BMO CapitalAnalyst unavailable$42$37.88 +13.0%Jan 13, 2026
UBSAnalyst unavailable$43$38.05 +15.7%Dec 17, 2025
Morgan StanleyDavid Arcaro$36$38.19 -3.1%Dec 16, 2025
KeyBancSophie Karp$41$37.31 +10.3%Dec 12, 2025
Wells FargoShahriar Pourreza$44$39.74 +18.4%Oct 27, 2025
Mizuho SecuritiesAnalyst unavailable$42$40.01 +13.0%Oct 21, 2025
Morgan StanleyAnalyst unavailable$39$39.88 +5.0%Oct 21, 2025
BarclaysAnalyst unavailable$41$40.22 +10.3%Oct 21, 2025
UBSAnalyst unavailable$46$39.11 +23.8%Oct 10, 2025
BarclaysAnalyst unavailable$40$39.46 +7.6%Oct 7, 2025
Evercore ISIAnalyst unavailable$42$39.46 +13.0%Oct 6, 2025
BMO CapitalJames Thalacker$41$38.17 +10.3%Oct 2, 2025
Mizuho SecuritiesAnalyst unavailable$40$39.13 +7.6%Sep 30, 2025
Morgan StanleyDavid Arcaro$38$38 +2.3%Aug 21, 2025
Mizuho SecuritiesAnthony Crowdell$39$38.36 +5.0%Jul 25, 2025
ScotiabankAndrew Weisel$40$38.02 +7.6%Apr 25, 2025
UBSWilliam Appicelli$37$31.99 -0.4%Dec 3, 2024
BMO CapitalJames Thalacker$34$32.76 -8.5%Nov 27, 2024
ScotiabankAndrew Weisel$30$29.74 -19.3%Oct 29, 2024
BarclaysNicholas Campanella$29$29.57 -22.0%Oct 14, 2024
ScotiabankAndrew Weisel$28$29.7 -24.7%Oct 1, 2024
Morgan StanleyDavid Arcaro$32$28.64 -13.9%Sep 25, 2024
CitigroupRyan Levine$34$28.21 -8.5%Sep 16, 2024
Bank of America SecuritiesRoss Fowler$29$27.95 -22.0%Sep 12, 2024
BMO CapitalJames Thalacker$28$27.09 -24.7%Aug 26, 2024
KeyBancSophie Karp$31$28.96 -16.6%Jul 22, 2024
BMO CapitalJames Thalacker$33$30.5 -11.2%Jun 26, 2024
KeyBancSophie Karp$33$30.08 -11.2%May 20, 2024
BMO CapitalJames Thalacker$32$28.94 -13.9%Apr 25, 2024
Morgan StanleyAnalyst unavailable$31$30.53 -16.6%Dec 15, 2022
Morgan StanleyAnalyst unavailable$29$29.15 -22.0%Nov 11, 2022
Credit SuisseAnalyst unavailable$34$31.75 -8.5%Apr 26, 2022
Morgan StanleyAnalyst unavailable$34$32.74 -8.5%Apr 20, 2022
Wells FargoAnalyst unavailable$36$32.08 -3.1%Apr 19, 2022
CitigroupRyan Levine$29$26.49 -22.0%Feb 23, 2022
UBSRoss Fowler$30$26.72 -19.3%Feb 15, 2022
Goldman SachsInsoo Kim$30$27.25 -19.3%Jan 12, 2022
ScotiabankAndrew Weisel$29$27.91 -22.0%Dec 15, 2021
GuggenheimShahriar Pourreza$29$26.16 -22.0%Nov 4, 2021
Show less

Track every rating change on CNP the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

CenterPoint Energy, Inc. operates as a public utility holding enterprise across the United States, primarily through its Electric and Natural Gas divisions. The Electric segment manages power generation assets, alongside the transmission and distribution networks that supply electricity to consumers, and actively participates in the wholesale power market. Its Natural Gas segment delivers natural gas distribution services, provides home appliance maintenance and repair in Minnesota, and extends home repair protection plans to natural gas customers in Arkansas, Indiana, Mississippi, Ohio, Oklahoma, Texas, and Louisiana through a third-party…

Historical context

All CNP earnings

Latest beats and misses

Who reports next

Get the CNP recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-28T23:04:11.899257+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-23T23:00:52.760182+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T23:00:52.757397+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.